World's Best Scientists 2026 revealed!
Alessandro M. Vannucchi

Alessandro M. Vannucchi

Award Badge
Medicine
Italy
2023

D-Index & Metrics

Medicine

D-Index
124
Citations
67473
World Ranking
3185
National Ranking
89

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Alessandro M. Vannucchi is affiliated with the University of Florence in Italy. Their research primarily focuses on medical science, with a significant emphasis on genetics, hematology, molecular biology, rheumatology, and immunology. Over their career, they have contributed extensively to the understanding of various hematologic conditions and diseases.

The main topics covered in Vannucchi's work include:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Kruppel-like factors research
  • Multiple Myeloma Research and Treatments
  • Hemoglobinopathies and Related Disorders

Among their recent notable publications are:

  • International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data, 2022, Blood
  • Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera, 2020, British Journal of Haematology
  • Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia, 2022, Blood
  • Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study, 2023, The Lancet
  • Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study, 2020, The Lancet Haematology

The venues where Vannucchi has most frequently published include:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • American Journal of Hematology
  • Blood Cancer Journal
  • Leukemia

Vannucchi has collaborated extensively with several researchers in their field, particularly with:

  • Paola Guglielmelli
  • Jean-Jacques Kiladjian
  • Claire Harrison
  • Ruben A. Mesa
  • Srđan Verstovšek

Their publication record includes over 900 works primarily situated within medicine and its related subfields. The integration of genomic data with clinical and morphologic analysis remains a prominent feature in their research, contributing to better diagnostic and prognostic systems in hematology.

Best Publications

  • Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2

    J. Nangalia;C.E. Massie;E.J. Baxter;F.L. Nice

  • JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.

    Claire Harrison;Jean Jacques Kiladjian;Haifa Kathrin Al-Ali;Heinz Gisslinger

  • New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.

    Francisco Cervantes;Brigitte Dupriez;Arturo Pereira;Francesco Passamonti

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

    Alessandro M. Vannucchi;Jean Jacques Kiladjian;Martin Griesshammer;Tamas Masszi

  • Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

    Roberto Marchioli;Guido Finazzi;Giorgina Specchia;Rossella Cacciola

  • Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

    Ayalew Tefferi;Juergen Thiele;Attilio Orazi;Hans Michael Kvasnicka

  • Mutations and prognosis in primary myelofibrosis

    Alessandro Maria Vannucchi;Tl Lasho;Paola Guglielmelli;Flavia Biamonte

  • A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

    Francesco Passamonti;Francisco Cervantes;Alessandro Maria Vannucchi;Enrica Morra

  • Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study

    A Tefferi;E Rumi;G Finazzi;H Gisslinger

  • Long-term survival and blast transformation in molecularly-annotated essential thrombocythemia, polycythemia vera and myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Dirk R. Larson;Christy Finke

  • Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

    Tiziano Barbui;Guido Finazzi;Alessandra Carobbio;Juergen Thiele

  • Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Rambaldi

  • Effect of Mutation Order on Myeloproliferative Neoplasms

    Christina A. Ortmann;David G. Kent;Jyoti Nangalia;Yvonne Silber

  • The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.

    Tiziano Barbui;Jürgen Thiele;Heinz Gisslinger;Hans Michael Kvasnicka

  • Classification and Personalized Prognosis in Myeloproliferative Neoplasms.

    Jacob Grinfeld;Jyoti Nangalia;E Joanna Baxter;David C Wedge

  • Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

    Tiziano Barbui;Juergen Thiele;Francesco Passamonti;Elisa Rumi

  • Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis

    C.N Harrison;A.M. Vannucchi;J.-J. Kiladjian;H.K. Al-Ali

  • Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet

    Tiziano Barbui;Ayalew Tefferi;Alessandro M. Vannucchi;Francesco Passamonti

  • Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.

    G. Barosi;R. A. Mesa;J. Thiele;F. Cervantes

Frequent Co-Authors

Paola Guglielmelli
Paola Guglielmelli University of Florence
Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
Francesco Passamonti
Francesco Passamonti University of Milan
Claire N. Harrison
Claire N. Harrison Guy's and St Thomas' NHS Foundation Trust
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Alberto Bosi
Alberto Bosi University of Florence
Ruben A. Mesa
Ruben A. Mesa The University of Texas Health Science Center at San Antonio
Francisco Cervantes
Francisco Cervantes University of Barcelona
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Giovanni Barosi
Giovanni Barosi University of Pavia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA offers many online degree options for students at every stage. Aspiring nurses and healthcare professionals can advance their education and open new career doors while enjoying the flexibility of remote learning.

If you’re a registered nurse seeking an affordable route to further your qualifications, you might be interested in the cheapest online rn to bsn programs. These programs enable RNs to earn a bachelor’s degree and expand their career opportunities. For nurses aiming for the highest level of clinical practice, the cheapest dnp online program can help lower costs while achieving advanced expertise.

Non-nursing graduates considering a switch to nursing can benefit from msn direct entry programs online, which offer a quicker path to a master’s degree for those holding a non-nursing bachelor’s. If you’re worried about competitiveness, discover what is the easiest nursing school to get into and find out which schools offer more accessible admission criteria.

Researching these options can help you choose the right pathway based on your goals, background, and budget.

Best Scientists Citing Alessandro M. Vannucchi

Trending Scientists